1. Antiemetics for Cancer Chemotherapy—Induced Nausea and Vomiting

   • André N. Rizk
   • Paul J. Hesketh

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 229 - 235

2. Antiemetics for Cancer Chemotherapy—Induced Nausea and Vomiting

   • Katharine J. Palmer
   • Raewyn Poole

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 237 - 239

3. CJ 11974

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 241 - 242

4. Itasetron

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 243 - 244

5. Lerisetron

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 245 - 246

6. Levosulpiride

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 247 - 248

7. MK 869

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 249 - 250

8. Palonosetron

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 251 - 252

9. Zatosetron

   Section 1: Antiemetics in Oncology 11 December 2012 Pages: 253 - 255

10. Agents in Development for the Treatment of Hepatitis C

    • Chris Dunn
    • Michelle Wilde
    • Richelle Paterson

    Section 2: Depatitis C 11 December 2012 Pages: 259 - 264

11. Acetylcysteine

    Section 2: Depatitis C 11 December 2012 Pages: 265 - 266

12. Aldesleukin

    Section 2: Depatitis C 11 December 2012 Pages: 267 - 270

13. Interferon-α-n3

    Section 2: Depatitis C 11 December 2012 Pages: 271 - 273

14. Maxamine™

    Section 2: Depatitis C 11 December 2012 Pages: 274 - 275

15. MTH 68/B

    Section 2: Depatitis C 11 December 2012 Pages: 276 - 277

16. PEG interferon-α-2a

    Section 2: Depatitis C 11 December 2012 Pages: 278 - 280

17. Ursodeoxycholic Acid

    Section 2: Depatitis C 11 December 2012 Pages: 281 - 283